Sorafenib combination with imatinib enhances apoptotic and cell cycle arrest effects with no effect on viability and BCR-ABL expression of K-562 cells

Belal A. Al-Husein, Ahmad Al-Azayzih, Fatema S. Redha

DOI: 10.7324/JAPS.2024.161424Pages:

Graphical Abstract